Correction to: ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2—Diagnostic criteria and appropriate utilization (Journal of Nuclear Cardiology, (2020), 27, 2, (659-673), 10.1007/s12350-019-01761-5)

Sharmila Dorbala, Yukio Ando, Sabahat Bokhari, Angela Dispenzieri, Rodney H. Falk, Victor A. Ferrari, Marianna Fontana, Olivier Gheysens, Julian D. Gillmore, Andor W.J.M. Glaudemans, Mazen A. Hanna, Bouke P.C. Hazenberg, Arnt V. Kristen, Raymond Y. Kwong, Mathew S. Maurer, Giampaolo Merlini, Edward J. Miller, James C. Moon, Venkatesh L. Murthy, C. Cristina QuartaClaudio Rapezzi, Frederick L. Ruberg, Sanjiv J. Shah, Riemer H.J.A. Slart, Hein J. Verberne, Jamieson M. Bourque

Research output: Contribution to journalComment/debatepeer-review

Abstract

• In the Introduction SCMR was listed incorrectly. SCMR is the Society for Cardiovascular Magnetic Resonance. • Table 1. Criteria for Diagnosis, ‘Clinical Diagnosis of ATTR…,’ number should begin with ‘‘1.’’ • Table 2. Erroneously printed without Clinical scenario 7. ‘Prior testing suggestive of cardiac amyloidosis.’ Please see revised Table 2.

Original languageEnglish (US)
Pages (from-to)1763-1767
Number of pages5
JournalJournal of Nuclear Cardiology
Volume28
Issue number4
DOIs
StatePublished - Aug 2021

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Correction to: ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2—Diagnostic criteria and appropriate utilization (Journal of Nuclear Cardiology, (2020), 27, 2, (659-673), 10.1007/s12350-019-01761-5)'. Together they form a unique fingerprint.

Cite this